ai offer real-world benefit
AI offers real-world benefits to healthcare
Matt DeCamp, associate professor with the Center for Bioethics and Humanities from CU Anschutz, framed the AI landscape: Up to $6 billion anticipated for AI investment into biomedical research by 2021 At least 14 recent AI-related FDA approvals in past two years, mostly in imaging, ophthalmology and pathology 55 active or pending clinical trials using the term "deep learning" 141 startup biotech companies using AI Insurance companies actively using AI to review records and optimize care for chronic conditions